These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2. McCluggage WG, Shah R, Connolly LE, McBride HA. Int J Gynecol Pathol; 2008 Jan 15; 27(1):92-100. PubMed ID: 18156982 [Abstract] [Full Text] [Related]
26. Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach. Lagendijk JH, Mullink H, van Diest PJ, Meijer GA, Meijer CJ. J Clin Pathol; 1999 Apr 15; 52(4):283-90. PubMed ID: 10474521 [Abstract] [Full Text] [Related]
28. Thyroid transcription factor-1 and cytokeratins 7 and 20 in pulmonary and breast carcinoma. Harlamert HA, Mira J, Bejarano PA, Baughman RP, Miller MA, Whitsett JA, Yassin R. Acta Cytol; 1998 Apr 15; 42(6):1382-8. PubMed ID: 9850647 [Abstract] [Full Text] [Related]
29. Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura. Cury PM, Butcher DN, Fisher C, Corrin B, Nicholson AG. Mod Pathol; 2000 Feb 15; 13(2):107-12. PubMed ID: 10697265 [Abstract] [Full Text] [Related]
30. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin. Tsao SC, Su YC, Wang SL, Chai CY. Kaohsiung J Med Sci; 2007 Jul 15; 23(7):325-31. PubMed ID: 17606426 [Abstract] [Full Text] [Related]
31. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature. Ordóñez NG. Am J Clin Pathol; 1998 Jan 15; 109(1):85-9. PubMed ID: 9426522 [Abstract] [Full Text] [Related]
32. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions. al-Saffar N, Hasleton PS. Eur Respir J; 1990 Oct 15; 3(9):997-1001. PubMed ID: 1705232 [Abstract] [Full Text] [Related]
35. Utility of CK7 and CK20 immunohistochemistry in the detection of synchronous breast and colon carcinoma in a pleural effusion: a case report and supporting survey of archival material. Stopyra GA, Warhol MJ, Multhaupt HA. Diagn Cytopathol; 2001 Jul 15; 25(1):54-8. PubMed ID: 11466814 [Abstract] [Full Text] [Related]
36. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects]. Chenard-Neu MP, Bellocq JP, Maier A, Batzenschlager A. Ann Pathol; 1990 Jul 15; 10(1):20-7. PubMed ID: 2328062 [Abstract] [Full Text] [Related]
37. Utility of thyroid transcription factor-1 and cytokeratin 7 and 20 immunostaining in the identification of origin in malignant effusions. Jang KY, Kang MJ, Lee DG, Chung MJ. Anal Quant Cytol Histol; 2001 Dec 15; 23(6):400-4. PubMed ID: 11777274 [Abstract] [Full Text] [Related]